Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Sell
35
BNL Quote, Financials, Valuation and Earnings
Last price:
$16.86
Seasonality move
:
6.7%
Day range:
$17.04 - $17.20
52-week range:
$14.21 - $19.15
Dividend yield:
6.77%
P/E ratio:
19.60x
P/S ratio:
7.76x
P/B ratio:
1.07x
Volume:
1.8M
Avg. volume:
1.4M
1-year change:
10.43%
Market cap:
$3.2B
Revenue:
$431.8M
EPS (TTM):
$0.87
Analysts' Opinion
-
Consensus RatingBroadstone Net Lease has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $18.89, Broadstone Net Lease has an estimated upside of 10.79% from its current price of $17.05.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $15.00 representing 100% downside risk from its current price of $17.05.
Fair Value
-
According to the consensus of 7 analysts, Broadstone Net Lease has 10.79% upside to fair value with a price target of $18.89 per share.
BNL vs. S&P 500
-
Over the past 5 trading days, Broadstone Net Lease has underperformed the S&P 500 by -1.15% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Broadstone Net Lease does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Broadstone Net Lease has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Broadstone Net Lease reported revenues of $112.1M.
Earnings Growth
-
Broadstone Net Lease has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Broadstone Net Lease reported earnings per share of $0.14.
Enterprise value:
5.3B
EV / Invested capital:
1.04x
Price / LTM sales:
7.76x
EV / EBIT:
21.52x
EV / Revenue:
12.17x
PEG ratio (5yr expected):
3.21x
EV / Free cash flow:
20.25x
Price / Operating cash flow:
12.91x
Enterprise value / EBITDA:
13.12x
Gross Profit (TTM):
$407.1M
Return On Assets:
3.09%
Net Income Margin (TTM):
37.62%
Return On Equity:
5.11%
Return On Invested Capital:
3.19%
Operating Margin:
46.78%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $407.5M | $442.9M | $431.8M | $105M | $112.1M | |
| Gross Profit | $385.7M | $420.3M | $407.1M | $99M | $105.4M | |
| Operating Income | $193.6M | $222.3M | $212.9M | $50.3M | $52.5M | |
| EBITDA | $364.2M | $402.8M | $400.4M | $64.8M | $90.7M | |
| Diluted EPS | $0.72 | $0.82 | $0.87 | $0.03 | $0.14 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $204.2M | $139.9M | $158.8M | $173.7M | $180.8M | |
| Total Assets | $4.3B | $4.6B | $5.5B | $5.3B | $5.2B | |
| Current Liabilities | $79M | $90.4M | $109.1M | $110.1M | $113.1M | |
| Total Liabilities | $1.8B | $1.9B | $2.2B | $2.1B | $2.1B | |
| Total Equity | $2.5B | $2.7B | $3.3B | $3.2B | $3.1B | |
| Total Debt | $1.5B | $1.7B | $2B | $1.9B | $1.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $255.9M | $271.1M | $276.3M | $60.6M | $63.9M | |
| Cash From Investing | -$859.6M | $24.3M | -$59.7M | -$49.5M | $27.3M | |
| Cash From Financing | $636M | -$334.8M | -$221.2M | -$40.9M | -$86.5M | |
| Free Cash Flow | $224.5M | $224.8M | $259.5M | $43.8M | $57.5M | |
BNL
Sector
Market Cap
$3.2B
$1B
Price % of 52-Week High
89.03%
81.16%
Dividend Yield
6.77%
3.29%
Shareholder Yield
--
3.37%
1-Year Price Total Return
10.43%
-0.5%
Beta (5-Year)
--
0.886
Dividend yield:
6.77%
Annualized payout:
$1.16
Payout ratio:
133.44%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$17.09
200-day SMA
Buy
Level
$17.01
Bollinger Bands (100)
Buy
Level
15.8 - 17.3
Chaikin Money Flow
Sell
Level
-4.4M
20-day SMA
Buy
Level
$16.95
Relative Strength Index (RSI14)
Buy
Level
56.07
ADX Line
Buy
Level
17.9
Williams %R
Neutral
Level
-37.0588
50-day SMA
Buy
Level
$16.24
MACD (12, 26)
Buy
Level
0.24
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Neutral
Level
28.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.9846)
Buy
CA Score
(Annual)
Level (0.1314)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.974)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants’ businesses and are therefore opportunities to secure long-term net leases.
Stock Forecast FAQ
In the current month, BNL has received 2 Buy ratings 5 Hold ratings, and 0 Sell ratings. The BNL average analyst price target in the past 3 months is $18.89.
-
Where Will Broadstone Net Lease Stock Be In 1 Year?
According to analysts, the consensus estimate is that Broadstone Net Lease share price will rise to $18.89 per share over the next 12 months.
-
What Do Analysts Say About Broadstone Net Lease?
Analysts are divided on their view about Broadstone Net Lease share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Broadstone Net Lease is a Sell and believe this share price will drop from its current level to $15.00.
-
What Is Broadstone Net Lease's Price Target?
The price target for Broadstone Net Lease over the next 1-year time period is forecast to be $18.89 according to 7 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is BNL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Broadstone Net Lease is a Hold. 5 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of BNL?
You can purchase shares of Broadstone Net Lease via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Broadstone Net Lease shares.
-
What Is The Broadstone Net Lease Share Price Today?
Broadstone Net Lease was last trading at $16.86 per share. This represents the most recent stock quote for Broadstone Net Lease. Yesterday, Broadstone Net Lease closed at $17.05 per share.
-
How To Buy Broadstone Net Lease Stock Online?
In order to purchase Broadstone Net Lease stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is down 13.55% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.38% over the past day.
Buy
51
CAR alert for Mar 28
Avis Budget Group [CAR] is down 0.22% over the past day.
